An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to recent findings.
Investigational Treatment Gaining Popularity Via Social Media
Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Viewers are urged to contact these profiles privately for source information, while also obtaining discount codes.
Active Commerce on Messaging Platforms
Additionally, a robust market exists on messaging services, where groups with thousands of participants share comparison photos, injection guides and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could lead to users administering products of unknown origin.
Some professionals said the demand for the experimental drug could be linked to the increasing cost of licensed weight loss products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or imprisonment.
Service Reaction and Material Removal
According to the social media company, the service has taken down violative material and prohibited related hashtags and search suggestions. The organization said it was dedicated to keeping the service safe and investing in strengthening compliance measures.
Online Trading Operations
Investigations also found groups with up to 9,000 members selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays groups with numerous of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at residence.
Within moments of joining one group, a seller posted WhatsApp details, where the majority of transactions occur. The seller sent an guidebook and promised delivery within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.
Product Details and Pricing
Inside these groups, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When questioned how long a injector should be used, vendors give contradictory answers varying between a several days to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering materials they cannot confirm. Although the research behind this drug is valid, these online versions may not contain what they claim,” said a pharmacy expert, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With prices rising, patients are using social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has previously encountered patients harmed by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially serious health risks”.
